FDA set to pilot test real-time tracking of clinical trials
Source: Yahoo! News/ABC News
Tue, April 28, 2026 at 5:48 PM EDT
The Food and Drug Administration (FDA) is set to pilot test real-time clinical trials in the hopes of expediting results and feedback, federal health officials announced on Tuesday.
At least two clinical trials by pharmaceutical companies AstraZeneca and Amgen will test the new system to alert FDA officials to study results in real time.
AstraZeneca is conducting a Phase 2 clinical trial in patients who have not received treatment yet for mantle cell lymphoma, a rare type of non-Hodgkin lymphoma. Amgen is conducting an early-stage clinical trial in patients with lung carcinoma.
Officials hope that real-time test results will allow for quicker feedback as to whether a drug or a device is providing meaningful benefits or potentially poses a safety concern to study participants.
Read more: https://www.yahoo.com/news/articles/fda-set-pilot-test-real-202947689.html